Providing Ophthalmic Instruments and Accessories to the

Irvine, CA—Visiogen Inc. says it has received FDA approval to expand its phase III U.S. clinical trial for its dual-optic accommodating IOL (Synchrony). (Source: Ophthalmology Times - Ophthalmic News)